To assess whether the reduced tumor size/weight in Oct4A KD cell-derived tumors may result from reduced tumor vascularity, we assessed the expression of human specific angiogenesis markers CD31 and CD34 on mouse xenografts. The gene discussed is CD34; the disease is neoplasm.